We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.78B
AUM Growth
+$1.86B
Cap. Flow
+$1.52B
Cap. Flow %
26.37%
Top 10 Hldgs %
27.07%
Holding
7,146
New
1,119
Increased
2,707
Reduced
2,319
Closed
677

Sector Composition

Rank Sector Weight
1 Technology 25.28%
2 Consumer Discretionary 10.53%
3 Financials 9.98%
4 Healthcare 8.97%
5 Communication Services 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRTY icon
1801
ProShares UltraPro Short Russell2000
SRTY
$66M
$193K ﹤0.01%
1,150
-6,132
-84% -$1.04M
CDMO
1802
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$193K ﹤0.01%
6,624
-5,201
-44% -$149K
AI icon
1803
C3.ai
AI
$1.57B
$192K ﹤0.01%
6,126
+2,756
+82% +$112K
ALE
1804
DELISTED
Allete
ALE
$192K ﹤0.01%
2,884
-3,934
-58% -$246K
CODX
1805
Co-Diagnostics
CODX
$5.23M
$192K ﹤0.01%
716
+631
+742% +$166K
BMBL icon
1806
Bumble
BMBL
$363M
$191K ﹤0.01%
5,632
+2,388
+74% +$102K
FNB icon
1807
FNB Corp
FNB
$6.93B
$191K ﹤0.01%
15,758
-32,711
-67% -$395K
IAU icon
1808
iShares Gold Trust
IAU
$65B
$191K ﹤0.01%
+5,500
New +$188K
UE icon
1809
Urban Edge Properties
UE
$2.79B
$191K ﹤0.01%
10,039
+2,630
+35% +$48.2K
ZLAB icon
1810
Zai Lab
ZLAB
$2.9B
$191K ﹤0.01%
3,040
+1,455
+92% +$123K
KOP icon
1811
Koppers
KOP
$872M
$190K ﹤0.01%
6,080
+5,044
+487% +$165K
PACB icon
1812
Pacific Biosciences
PACB
$354M
$190K ﹤0.01%
9,297
-5,866
-39% -$142K
RDS.B
1813
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$190K ﹤0.01%
+4,383
New +$198K
SLGN icon
1814
Silgan Holdings
SLGN
$4.41B
$189K ﹤0.01%
4,411
+1,315
+42% +$54.3K
CERE
1815
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$189K ﹤0.01%
5,830
-6,263
-52% -$221K
BHR
1816
Braemar Hotels & Resorts
BHR
$139M
$188K ﹤0.01%
36,925
+34,521
+1,436% +$170K
OPCH icon
1817
Option Care Health
OPCH
$3.59B
$188K ﹤0.01%
6,596
-5,852
-47% -$154K
RVMD icon
1818
Revolution Medicines
RVMD
$43.1B
$188K ﹤0.01%
7,483
+1,417
+23% +$39.9K
TMP icon
1819
Tompkins Financial
TMP
$1.48B
$188K ﹤0.01%
2,252
+10
+0.4% +$820
TNA icon
1820
Direxion Daily Small Cap Bull 3x ETF
TNA
$1.51B
$188K ﹤0.01%
+2,215
New +$200K
MYGN icon
1821
Myriad Genetics
MYGN
$298M
$187K ﹤0.01%
6,804
-2,415
-26% -$70K
SDD icon
1822
ProShares UltraShort SmallCap600
SDD
$1.3M
$187K ﹤0.01%
8,756
+7,463
+577% +$167K
TRIP icon
1823
TripAdvisor
TRIP
$1.29B
$187K ﹤0.01%
6,856
+645
+10% +$19.8K
SPWR
1824
DELISTED
SunPower Corporation Common Stock
SPWR
$187K ﹤0.01%
8,946
+3,038
+51% +$82.2K
CHNG
1825
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$187K ﹤0.01%
8,747
-2,026
-19% -$42.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2021 Portfolio in Review

As of Q4 2021, Tower Research Capital (TRC) held 7,146 positions worth $5.78B, up 48% from $3.92B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) deployed $1.52B of net new capital in Q4 2021, opening 1,119 new positions and adding to 2,707 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $404M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2021 buy was iShares Russell 1000 ETF: 47,514 shares worth $12.6M.
  • Tower Research Capital (TRC) added most to Microsoft in Q4 2021, an estimated $125M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $404M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P MIDCAP 400 ETF Trust in Q4 2021, selling an estimated $36.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $5.78B portfolio in Q4 2021.
  • Tower Research Capital (TRC) opened 1,119 new positions and closed 677 in Q4 2021.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $5.78B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2021, filed 14 Feb 2022.